Trial Profile
Randomised controlled trial of rituximab in active ulcerative colitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 06 Apr 2011 Results published in the Gut.
- 01 May 2010 Results presented at 2010 Digestive Disease Week.
- 01 May 2010 Status changed from recruiting to completed, due to presentation of results at 2010 Digestive Disease Week.